Similar articles for PMID: 20154629

Year	Number of Results
1982	1
1993	1
1997	1
2001	2
2002	2
2003	3
2005	5
2006	3
2007	2
2008	3
2009	7
2010	15
2011	4
2012	5
2013	10
2014	7
2015	4
2016	6
2017	5
2018	2
2019	13
2020	11
2021	4
2022	2
2023	1
2024	0

1

An evidence development process for newborn screening.

Perrin JM, Knapp AA, Browning MF, Comeau AM, Green NS, Lipstein EA, Metterville DR, Prosser L, Queally D, Kemper AR. Perrin JM, et al. Genet Med. 2010 Mar;12(3):131-4. doi: 10.1097/GIM.0b013e3181d28eb1. Genet Med. 2010. PMID: 20154629 Free article. Review. No abstract available.

2

Newborn screening conditions: What we know, what we do not know, and how we will know it.

Levy HL. Levy HL. Genet Med. 2010 Dec;12(12 Suppl):S213-4. doi: 10.1097/GIM.0b013e3181fe5d77. Genet Med. 2010. PMID: 21150366 Free article.

3

Diagnostic guidelines for newborns who screen positive in newborn screening.

Kronn D, Mofidi S, Braverman N, Harris K; Diagnostics Guidelines Work Group. Kronn D, et al. Genet Med. 2010 Dec;12(12 Suppl):S251-5. doi: 10.1097/GIM.0b013e3181fe5d8b. Genet Med. 2010. PMID: 21150371 Free article.

4

New consent requirements for newborn screening raise concerns.

Yan W. Yan W. Nat Med. 2015 Jun;21(6):542-3. doi: 10.1038/nm0615-542. Nat Med. 2015. PMID: 26046566 No abstract available.

5

Leveraging Evidence-Based Public Policy and Advocacy to Advance Newborn Screening in California.

Bronstein MG, Pan RJ, Dant M, Lubin B. Bronstein MG, et al. Pediatrics. 2019 Feb;143(2):e20181886. doi: 10.1542/peds.2018-1886. Epub 2019 Jan 3. Pediatrics. 2019. PMID: 30606745 Review.

6

A framework to start the debate on neonatal screening policies in the EU: an Expert Opinion Document.

Cornel MC, Rigter T, Weinreich SS, Burgard P, Hoffmann GF, Lindner M, Gerard Loeber J, Rupp K, Taruscio D, Vittozzi L. Cornel MC, et al. Eur J Hum Genet. 2014 Jan;22(1):12-7. doi: 10.1038/ejhg.2013.90. Epub 2013 May 8. Eur J Hum Genet. 2014. PMID: 23652378 Free PMC article.

7

Medicine. Newborn screening: gaps in the evidence.

Wilcken B. Wilcken B. Science. 2013 Oct 11;342(6155):197-8. doi: 10.1126/science.1243944. Science. 2013. PMID: 24115426 No abstract available.

8

Table ronde 1 - État des lieux après 10 ou 15 ans d'actions pour les maladies rares.

[No authors listed] [No authors listed] Med Sci (Paris). 2016 Apr;32 Spec No 1:8-11. doi: 10.1051/medsci/201632s103. Epub 2016 May 2. Med Sci (Paris). 2016. PMID: 27137854 Free article. French. No abstract available.

9

Nonimmune Anemias.

Malec L. Malec L. Clin Perinatol. 2020 Mar;47(1):143-153. doi: 10.1016/j.clp.2019.09.006. Epub 2019 Sep 28. Clin Perinatol. 2020. PMID: 32000921 Review.

10

[Rare diseases and the CRISPR technology...].

Carayon P, Cler E, By Y. Carayon P, et al. Ann Biol Clin (Paris). 2016 Mar-Apr;74(2):125-9. doi: 10.1684/abc.2016.1131. Ann Biol Clin (Paris). 2016. PMID: 27029719 Free article. French. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

104 results

Results by year